Introducing a fashion line inspired by the two million Canadians affected by osteoporosis TORONTO, Feb. 6, 2019  – Models clad in stylish bubble wrap strutted down the Toronto Fashion Week® x […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

Calcium Supplementation When Your Doctor Advises You To Take A Calcium Supplement If you find it difficult to obtain the recommended amounts of calcium through diet alone, your physician may […]

Latest News IAB Membership Cycle Applications Being Accepted January 12, 2024 Canadian Institutes of Health Research (CIHR) The Canadian Institutes of Health Research (CIHR) is Canada’s federal funding agency for […]

SCIENTIFIC ADVISORY COUNCIL We look to the best experts to inform our care guidelines for patients and care providers. Our Scientific Advisory Council (SAC) is made up of experts in […]

Available Volunteer Opportunities Bone Health Education Presenter – Virtual Bone Health Education Volunteers work together with the Community Engagement Coordinators and are an integral part in the planning and facilitating […]

Osteoporosis Canada continues to advise Canadians to meet the Institute of Medicine established daily calcium requirement of 1000 -1200 mg, from dietary sources preferably, and to use supplements if this […]

General Information About Pain After A Fracture Pain is the body’s natural response when a bone breaks. Both the fracture and any injuries to the body tissue near the fracture […]

Denosumab (Prolia) has been shown to reduce the risk of fracture in postmenopausal women and men ≥50 years old with osteoporosis. It has also been approved for steroid induced bone […]